Upregulation of histone methyltransferase SET domain bifurcated 1 (SETDB1) is associated with poor prognosis in cancer patients. However, the mechanism of oncogenicity of SETDB1 in cancer is hitherto unknown. Here, we show that SETDB1 is upregulated in human colorectal cancer (CRC) where its level correlates with poor clinical outcome. Ectopic SETDB1 promotes CRC cell proliferation, whereas SETDB1 attenuation inhibits this process. Flow cytometry reveals that SETDB1 promotes proliferation by driving the CRC cell cycle from G0/G1 phase to S phase. Mechanistically, SETDB1 binds directly to the STAT1 promoter region resulting in increased STAT1 expression. Functional characterization reveals that STAT1-CCND1/CDK6 axis is a downstream effector of SETDB1-mediated CRC cell proliferation. Furthermore, SETDB1 upregulation is sufficient to accelerate in vivo proliferation in xenograft animal model. Taken together, our results provide insight into the upregulation of SETDB1 within CRC and can lead to novel treatment strategies targeting this cell proliferation-promoting gene.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/carcin/bgz131 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Structure and Methyl-lysine Binding Selectivity of the HUSH Complex Subunit MPP8.
J Mol Biol
December 2024
Molecular Immunity Unit, Department of Medicine, University of Cambridge, MRC Laboratory of Molecular Biology, Cambridge CB2 0QH, UK; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Department of Medicine, University of Cambridge, Cambridge CB2 0AW, UK. Electronic address:
The Human Silencing Hub (HUSH) guards the genome from the pathogenic effects of retroelement expression. Composed of MPP8, TASOR, and Periphilin-1, HUSH recognizes actively transcribed retrotransposed sequences by the presence of long (>1.5-kb) nascent transcripts without introns.
View Article and Find Full Text PDFMeioc-Piwil1 complexes regulate rRNA transcription for differentiation of spermatogonial stem cells.
bioRxiv
November 2024
Department of Gene Function and Phenomics, National Institute of Genetics.
Ribosome biogenesis is vital for sustaining stem cell properties, yet its regulatory mechanisms are obscure. Herein, we show unique properties of zebrafish mutants in which spermatogonial stem cells (SSCs) do not differentiate or upregulate rRNAs. Meioc colocalized with Piwil1 in perinuclear germ granules, but Meioc depletion resulted in Piwil1 accumulation in nucleoli.
View Article and Find Full Text PDFStem cell activity-coupled suppression of endogenous retrovirus governs adult tissue regeneration.
Cell
December 2024
Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Graduate School of Biomedical Sciences, UT MD Anderson Cancer Center UTHealth Houston, Houston, TX, USA. Electronic address:
Mammalian retrotransposons constitute 40% of the genome. During tissue regeneration, adult stem cells coordinately repress retrotransposons and activate lineage genes, but how this coordination is controlled is poorly understood. Here, we observed that dynamic expression of histone methyltransferase SETDB1 (a retrotransposon repressor) closely mirrors stem cell activities in murine skin.
View Article and Find Full Text PDFTargeting the Tumor Epigenetic Regulator SETDB1 for Tumor Therapy.
Curr Cancer Drug Targets
August 2024
School of life Sciences, Southwest University, No.2 Tiansheng Road., Beibei, Chongqing, China.
Epigenetic alterations are implicated in the early stages of tumorigenesis and are widely recognized as a ubiquitous phenomenon in cancer development. Aberrant epigenetic modifications can alter the expression of target genes, induce heterochromatin formation, and gradually drive normal cells towards immortalized tumor cells with significant consequences. SETDB1 (SET domain bifurcated histone lysine methyltransferase 1), a typical histone me-thyltransferase, promotes the formation of heterochromatin and inhibits the transcription of genes by modifying the methylation of lysine 9 of histone 3.
View Article and Find Full Text PDFAZD1775 synergizes with SLC7A11 inhibition to promote ferroptosis.
Sci China Life Sci
January 2025
Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China.
Article Synopsis
- The study investigates how the tumor suppressor p53 affects the effectiveness of the WEE1 inhibitor AZD1775 in promoting ferroptosis, a type of cell death, in lung cancer cells.
- AZD1775 inhibits cystine uptake, which is crucial for ferroptosis, and leads to increased expression of SLC7A11, a resistance factor, by altering histone modifications via the WEE1-SETDB1 pathway.
- Combining AZD1775 with the nucleolar stress inducer Actinomycin D enhances the ability to induce ferroptosis and suppress lung cancer growth, particularly in cells with functional p53.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!